# Q500 verify, round 4: s66, Multiple trauma

Fresh independent review by Preceptor of the revised batch `src/samps/s66/multiple-trauma.ts`, ids multiple-trauma-48 to multiple-trauma-52. This reviewer did not write, edit or earlier review this batch and edited no file except this verdict (REVIEW-RULES rule 1). Every fix below goes back to a writer, and the revision needs another fresh review. All items stay `reviewed: false`. This is an AI audit, not clinician verification.

Inputs read: the round 3 verdict (`docs/reviews/q500-verify3-s66.md`), "Round 4" in `docs/reviews/q500-writer-s66-r2.md`, the diff from fedd651, SAMP_SPEC, the SAMP review brief, REVIEW-RULES (rule 4), DECISIONS and SCORING-RULINGS (B6 on mock-mode cues). Uniqueness of the new 50 q4 was checked by grep over every file in the Q500 catalogue folder and over `src/samps` and `src/cases`.

Checks run: `SAMP_BATCH=s66 npx vitest run tests/samps.test.ts tests/samp-quality.test.ts tests/citations.test.ts` passed (3 files, 136 tests). The s66 type check prints nothing. House style scan: no em or en dashes, semicolons only in code, no characters outside ASCII except the degree sign, no mnemonics. `author: "Preceptor"`, `reviewed: false`, `version: 1`.

## Verdicts

| Id | Verdict | Questions that fail |
|---|---|---|
| multiple-trauma-48 | PASS | none |
| multiple-trauma-49 | PASS | none (unchanged) |
| multiple-trauma-50 | FAIL | q4 |
| multiple-trauma-51 | PASS | none (unchanged) |
| multiple-trauma-52 | PASS | none (unchanged) |

## Required fixes from round 3: were they applied?

| Item | Applied | Comment |
|---|---|---|
| 48 q1 option cue | Yes | All four vitals now read "Arrival ...". Options are in alphabetical order: Arrival pulse, Arrival respiratory rate, Arrival systolic BP, Arrival temperature, Blunt mechanism, Free fluid, Midline tenderness, Prehospital Ringer's lactate. `correct: [0, 2, 5]` maps to pulse 124/minute, systolic BP 88 mmHg and free fluid on eFAST, the same three findings as before. PASS. |
| 48 q1 source wording | Yes | "In the original study of the score" replaces "In the validation cohort". True to Nunez 2009, which set out to validate TASH and McLaughlin and proposed ABC in the same 596 patient cohort. PASS. |
| 50 acid-base (now q3), arrival values and volume | Yes | Arrival chloride 106 and bicarbonate 24 are now in the update, and "4 L more ... through peripheral lines" makes the volume plain. PASS (below). |
| 50 INR question (repeat of gi-bleed-33 q1) | Yes | Removed, with `cstm-cw`. Replaced by a new q4 on ward insulin orders. The new item fails on one invented fact (below). |
| 50 advisory, saline limit | Taken | Verified (below). |
| 50 advisory, IO timeline | Taken | The arm-swelling item is now q2, before the saline, and the q3 update says the saline ran through peripheral lines. The timeline now reads correctly. Unrequested in its exact form but asked for as an advisory, judged on its merits under rule 4: sound. |

## Per question

### multiple-trauma-48

- q1 PASS. Recomputed: ABC gives one point each for a penetrating mechanism, a positive FAST, arrival systolic BP 90 mmHg or less and arrival heart rate 120/minute or more. Her vitals are pulse 124/minute and BP 88/54 mmHg, and eFAST shows free fluid around the spleen. Blunt mechanism scores nothing. Score 3. Key [0, 2, 5] is correct and the only defensible set. "75% sensitive and 86% specific" at 2 or more is verbatim from the abstract. With "Arrival" on every vital, wording no longer separates keyed from unkeyed vitals. The temperature option (35.8°C) matches the vitals field. KF6 is an honest tag. Style only, not a failure: "In the original study of the score a score of 2 or more" repeats "score". A writer touching this line could write "In the original study, a score of 2 or more".
- q2, q3, q4 PASS. Unchanged since round 3.

### multiple-trauma-49

PASS. Unchanged (no diff hunk touches it).

### multiple-trauma-50

- q1 PASS. Unchanged.
- q2 PASS. Unchanged text, moved from q4. Key "IO fluid extravasation" (fifth). "After 1 L of fluid ran through it" matches the stem. Petitpas 2016 supports compartment syndrome from extravasation as the most frequent complication. The update no longer names or implies the q1 key.
- q3 PASS.
  - Recomputed: anion gap 142 minus (119 plus 16) = 7, normal. Chloride rose 13 (106 to 119) while bicarbonate fell 8 (24 to 16), which fits a dilutional, hyperchloremic acidosis. With an arrival sodium in the 140s, the arrival gap is about 10 to 12, normal, and the explanation makes no claim about it. Venous pH 7.28 with bicarbonate 16 fits a venous pCO2 near 35 mmHg. Lactate 1.1, beta-hydroxybutyrate 0.2 and creatinine 81 umol/L dispose of the four distractors with true reasons. One defensible key. KF5 kept.
  - Source: every quoted point is in the sixth edition full text (PMC9977110): base deficit reflects hypoperfusion "provided there is no other cause of metabolic acidosis such as renal failure or hyperchloremia", "lactate levels more specifically reflect the degree of tissue hypoperfusion", the concern that "saline as the main i.v. fluid results in harm to patients, such as hyperchloraemic acidosis", the authors "favour a balanced electrolyte solution", and "if a 0.9% sodium chloride solution is used, it should be limited to a maximum of 1–1.5 L". The new sentence is true to it.
  - The update is 45 words.
  - Physician-level, not a failure: a 13 mmol/L chloride rise after 4 L of saline in a 92 kg man is at the high end of what is seen (simple mixing into about 18 L of extracellular fluid predicts about 115 mmol/L).
- q4 FAIL (medium, invented fact, SAMP_SPEC section 8 and review brief Lens B 1).
  - What is right: the decision is new to the bank. Grep over every catalogue, `src/samps` and `src/cases` for glargine, basal insulin, sliding scale, correction insulin, basal bolus, holding or reducing insulin and "insulin orders" finds only stems that list glargine as a home drug, the abdominal-pain s19 DKA insulin item (infusion plus dextrose, a different decision), and hold-insulin distractors in s18 tox and s50 shock insulin overdose items (different decisions). It is not a repeat. Key "Reduced glargine and correction" sits fifth. Option lengths and order pass the tests. KF4 (modifying factors, here his insulin) is an acceptable tag, though looser than 48 q3 and 50 q1, and KF4 is covered without it. The distractor reasons are true: Diabetes Canada says "basal insulin should not be withheld", that bolus insulin "can be withheld or reduced in people who are not eating regularly", and that correction insulin is discouraged "as the sole modality for treating elevated blood glucose levels".
  - Problem: the explanation says "He was hypoglycemic enough to leave the road" and "His full home doses with little food risk another low". The case never gives a glucose value or says that he was hypoglycemic. Round 3 removed the glucose from the case on purpose so that it would not cue q1 (ruling B6). q1's own explanation says only that hypoglycemia "may have caused the crash". The explanation also applies the guideline's "If BG values are ≤3.9 mmol/L, modification of antihyperglycemic therapy is suggested" to a glucose the case does not report. So the reason given for reducing the glargine rests on a fact the case never gave.
  - Required change (keep the case free of a glucose value, because any glucose or "hypoglycemia" in a later update would cue q1 under B6). Replace the sentences from "and it suggests changing therapy" to "risk another low." with: "It lists a sudden fall in oral intake as a risk factor for hypoglycemia. He will eat little, and a low glucose may have caused his crash, so his glargine is continued at a lower dose, with correction aspart and a preprandial target of 5.0 to 8.0 mmol/L. Holding all insulin, or giving correction doses alone, leaves an insulin-treated patient without basal cover. His full home doses with little food risk hypoglycemia." The chapter's risk-factor list includes "sudden reduction in oral intake". Do not add a glucose value to any update. The key, options and update stay as they are.
  - Writer's flag 1, chapter year: accepted. The chapter 16 page shows "© 2018 Canadian Diabetes Association", and the chapter is part of the 2018 guidelines in Can J Diabetes, the same edition as the chapter 21 citation in this SAMP. No later in-hospital chapter replaces it.
  - Writer's flag 2, "He is not critically ill, so an IV insulin infusion is not needed": supported as written. The chapter says "most people with type 1 or type 2 diabetes admitted to general medical wards can be treated with subcutaneous insulin" and "Intravenous insulin, however, may be appropriate for people who are critically ill". The case supports "not critically ill" (alert, pulse 84/minute, BP 146/86 mmHg, admitted to the ward). No change required.
  - Advisory (low, not a failure): the update has "the admitting team" ask the emergency physician for ward insulin orders. That is plausible where emergency physicians write admission orders, but a writer could say "The trauma team asks you to write his first insulin orders".

### multiple-trauma-51

PASS. Unchanged.

### multiple-trauma-52

PASS. Unchanged.

## Key positions, format and coverage

Single key positions, first to fifth: 5, 4, 2, 4, 5 of 20 (25% at most, every position used). The required q4 fix does not touch options, so positions stay as they are. Menus: 48 q1 and 49 q1.

Key feature coverage, by tag: KF1 52 q1. KF2 49 q2, 49 q5, 52 q3. KF3 50 q2, 51 q1, 51 q2. KF4 48 q3, 50 q1, 50 q4. KF5 50 q3. KF6 48 q1, 51 q3. KF7 48 q2, 49 q1, 49 q3, 49 q4, 52 q2. KF8 48 q4, 51 q4, 52 q4, 52 q5. Every key feature is covered.

## Sources verified this round

- Nunez TC et al. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma. 2009. PubMed 19204506, abstract read through Europe PMC.
- Rossaint R et al. The European guideline on management of major bleeding and coagulopathy following trauma, sixth edition. Crit Care. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC9977110/, full text read (saline limit, balanced solution, base deficit, lactate, hyperchloremic acidosis).
- Diabetes Canada Clinical Practice Guidelines Expert Committee, Malcolm J, Halperin I, et al. In-hospital management of diabetes. Can J Diabetes. 2018. https://www.diabetes.ca/for-professionals/full-guidelines/chapter-16, page read: basal not withheld, bolus withheld or reduced when not eating, correction alone discouraged (recommendation 4), modification after BG of 3.9 mmol/L or less, preprandial 5.0 to 8.0 mmol/L, subcutaneous insulin for most ward patients and IV insulin for the critically ill, sudden reduction in oral intake as a hypoglycemia risk factor. The chapter does not give a basal dose reduction or percentage. The explanation's "lower dose" is a reasonable clinical step and does not claim a figure.

## Needs physician decision

- 50 q3: size of the chloride rise (above).
- 50 q4: the keyed lower glargine dose is an inference (reduced intake, possible hypoglycemia). The chapter supports continuing basal insulin and adjusting therapy, not a set reduction.

## Summary

5 SAMPs, 22 questions (20 single, 2 menu). 21 pass and 1 fails. Every round 3 fix was applied as asked. 48 q1 is fixed and passes. 50 q2 (moved) and 50 q3 (acid-base, with arrival values and the saline limit) pass. 49, 51 and 52 are unchanged. Tests pass.

Failure: multiple-trauma-50 q4. Its explanation states that he was hypoglycemic, but the case never gives that fact. Reword as above, and do not add a glucose to any update, because that would cue q1. The batch has not yet fully passed fresh review. Only multiple-trauma-50 needs another round.
